1. Home
  2. CPHC vs ICCC Comparison

CPHC vs ICCC Comparison

Compare CPHC & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Canterbury Park Holding Corporation 'New'

CPHC

Canterbury Park Holding Corporation 'New'

N/A

Current Price

$15.93

Market Cap

82.1M

ML Signal

N/A

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

HOLD

Current Price

$10.39

Market Cap

93.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPHC
ICCC
Founded
1994
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
82.1M
93.1M
IPO Year
2016
1995

Fundamental Metrics

Financial Performance
Metric
CPHC
ICCC
Price
$15.93
$10.39
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
809.0
★ 7.5K
Earning Date
11-05-2026
11-12-2026
Dividend Yield
★ 1.75%
N/A
EPS Growth
N/A
★ 53.85
EPS
N/A
★ 0.41
Revenue
★ $59,227,000.00
$26,493,169.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$523.00
★ $25.80
Revenue Growth
0.14
★ 51.64
52 Week Low
$14.39
$4.52
52 Week High
$16.84
$12.10

Technical Indicators

Market Signals
Indicator
CPHC
ICCC
Relative Strength Index (RSI) 55.33 51.84
Support Level $15.25 $9.45
Resistance Level $16.17 $10.82
Average True Range (ATR) 0.13 0.23
MACD 0.02 0.05
Stochastic Oscillator 87.06 51.36

Price Performance

Historical Comparison
CPHC
ICCC

About CPHC Canterbury Park Holding Corporation 'New'

Canterbury Park Holding Corp is in the business of pari-mutuel wagering on horse races and unbanked card games at its canterbury park racetrack and card casino facility in Minnesota. The company has four operating segments. The horse racing segment represents pari-mutuel wagering operations on simulcast and lives horse races; the Casino segment represents unbanked card operations; the food and beverage segment includes concessions, catering, and events services provided at the Racetrack; and the real estate development segment represents its real estate development operations. The firm generates a majority of its revenue from the Casino segment.

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

Share on Social Networks: